OUTCOMES OF OVARIAN TRANSPOSITION SURGERY BEFORE RADIOTHERAPY IN CERVICAL CANCER PATIENTS AT VIETNAM NATIONAL CANCER HOSPITAL
Main Article Content
Abstract
Objective: Evaluation of the results of ovarian transposition surgery and ovarian function before radiotherapy in cervical cancer patients at Vietnam National Cancer Hospital. Subjects and Methods: A retrospective and prospective descriptive study of 75 young cervical cancer patients who underwent ovarian transposition at Vietnam National Cancer Hospital from January 2023 to December 2024. Results: No complications were recorded after ovarian transposition (OT) surgery. After 6 months, 72% of patients retained ovarian function. The ovarian function preservation rate was 100% in the non-radiotherapy group, 66.7% in the adjuvant radiotherapy group, and 30.4% in the concurrent chemoradiotherapy group. Regarding sexual quality of life, 72% of patients reported normal or excellent quality. 100% of patients with loss of ovarian function had poor sexual quality of life, while among those with preserved ovarian function, 57.4% had average sexual quality of life and 42.6% had excellent quality. Conclusion: Ovarian transposition is a safe and effective surgical procedure for preserving ovarian endocrine function and contributing to the maintenance of sexual quality of life in young women with cervical cancer. The degree of ovarian function preservation gradually decreases with radiotherapy and chemoradiotherapy.
Article Details
Keywords
Cervical cancer, ovarian transposition, ovarian function, sexual quality of life, FSFI, radiotherapy
References
2. Viet Nam: Human Papillomavirus and Related Cancers, Fact Sheet 2023. Viet Nam. Published online 2023.
3. Đánh giá kết quả điều trị ung thư cổ tử cung giai đoạn figo ib1-iia1 bằng phương pháp phẫu thuật tại Bệnh viện K. Accessed May 9, 2024. https://tapchiyhocvietnam.vn/index. php/vmj/article/view/1536/1362
4. Wallace WHB, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738-744. doi:10.1016/j.ijrobp.2004.11.038
5. Laios A, Duarte Portela S, Papadopoulou A, Gallos ID, Otify M, Ind T. Ovarian transposition and cervical cancer. Best Practice & Research Clinical Obstetrics & Gynaecology. 2021;75:37-53. doi:10.1016/j.bpobgyn.2021.01.013
6. Kuria M, Gitau S, Warfa K. Cervical cancer with bilateral ovarian metastases: case report and review of literature. BJR|Case Reports. 2018;4(4):20180047. doi:10.1259/bjrcr.20180047
7. Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertility and Sterility. 2000;74(4):743-748. doi:10.1016/S0015-0282(00)01500-4
8. Trần Đặng Ngọc Linh, Nguyễn Thế Kỷ Cương. Ảnh hưởng của xạ trị lên chức năng buồng trứng ở bệnh nhân ung thư cổ tử cung được phẫu thuật chuyển vị buồng trứng. Hội thảo hàng năm phòng chống ung thư tp hồ chí minh lần thứ 26. Published online 2023.
9. Hoekman EJ, Knoester D, Peters AAW, Jansen FW, de Kroon CD, Hilders CGJM. Ovarian survival after pelvic radiation: transposition until the age of 35 years. Arch Gynecol Obstet. 2018;298(5):1001-1007. doi:10. 1007/s00404-018-4883-5
10. Li Z, Qi H, Li Z, Bao Y, Yang K, Min Q. Research progress on the premature ovarian failure caused by cisplatin therapy. Front Oncol. 2023;13. doi:10.3389/fonc.2023.1276310